FDA Inspection 1087253 — FOAMIX PHARMACEUTICALS, INC.

FOAMIX PHARMACEUTICALS, INC. — FEI 3013131092

The FDA completed an inspection of FOAMIX PHARMACEUTICALS, INC. on Apr 24, 2019 in Bridgewater, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bridgewater, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
741021 CFR 312.53(a)Investigator selection
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.